Coverage
-
January 11, 2016
A federal judge ruled Friday that Apotex's planned generic version of Daiichi Sankyo's blood pressure drug Benicar does not infringe a patent that Daiichi previously disclaimed, a decision that could reduce the generic exclusivity period held by Apotex's rival generics maker Mylan.
2 other articles on this case.
View all »